Molecular Diagnostics
Results of Alzheimer’s Disease Blood Tests Are Skewed by Unrelated Chronic Conditions
The affect of chronic medical conditions such as chronic kidney disease on circulating levels of phosphorylated tau proteins (p-tau) must be evaluated before a p-tau blood test can be used for diagnosis of Alzheimer’s disease and other forms of dementia. More...02 Jun 2022
Liquid Biopsy Predicts Success of ICI Treatment in Lung Cancer Patients
Compared to an invasive tumor biopsy procedure, an extracellular vesicle-based liquid biopsy method was shown to better predict treatment response and survival in patients with non-small cell lung cancer who were undergoing treatment with immune-checkpoint inhibitors (ICIs). More...02 Jun 2022
Molecular Profiling Identifies High-Risk Subtype of Pediatric Liver Cancer
Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the most common primary liver malignancies in children, adolescents, and young adults. HB is usually diagnosed in young children and has shown an unequivocal rise in incidence, representing the pediatric cancer with the highest average annual percent increase in incidence over the past three decades. More...01 Jun 2022
Roche Develops Monkeypox Virus Detection PCR Tests
In response to the recent monkeypox virus concerns, Roche Diagnostics (Basel, Switzerland) and its subsidiary TIB Molbiol (Berlin, Germany) have developed three unique LightMix Modular Virus kits for the detection of the monkeypox virus. More...31 May 2022
POC Critical Illness Test Designed for Early Warning and Patient Triaging
An easy-to-use, quantitative test for early warning and patient triaging measures levels of the prognostic biomarker suPAR to allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome. More...31 May 2022
Gold Member
Hybrid Pipette
SWITCH
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Clinical Chemistry System
P780
In Other News
Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases
Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy
LumiraDx HbA1c Assay Screens and Identifies Patients at Risk for Developing Diabetes
POC System Could Transform Infectious Disease Management
mRNA Test Screens for Multiple Cancers from Single Blood Sample
A Circulating Antibody Enables Prediction of Crohn’s Disease Long Before Symptoms Appear
Bioperfectus Monkeypox Virus Real Time PCR Kit Receives CE Mark
Blood Test Detects Markers for Liver Injury from Acetaminophen Overdose in 20 Minutes
Next-Generation Sequencing Enables Diagnosis of Primary Immunodeficiency Disorders
Clinical Multiplex Benchtop Diagnostic System Runs Tests Directly From Whole Blood
Blood Test Predicts Response to Immunotherapy in Patients with Non-Small Cell Lung Cancer
ALL Genomes Marked by High DNA Methylation Levels
Circulating Tumor DNA Test Clinically Validated
High-Resolution Mass Spectrometry-Based Test Diagnoses Alzheimer’s Disease
Multiplex PCR-Based Test Detects UTI Pathogens and Antimicrobial Resistance Genes
Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer
Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis
Revolutionary Blood Test to Transform Early Diagnosis of Bowel Cancer
Mass Spectrometry Could Enable Early Prediction of Alzheimer’s Disease from Blood Samples
Study Identifies Molecular Signatures in Arthritis Patients for Incorporation In Diagnostic Tests
Biosensor Technology Could Pave Way for POC Diagnosis of Cancer, Pathogens, and Other Diseases
Nasal Swab Test Accurately Assesses Lung Cancer Risk Among Smokers with Lung Nodules
Qiagen Launches RT qPCR Test for Sensitive Detection of EGFR Mutations to Guide NSCLC Treatment
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.